| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.62▼ | 4.60▲ | 4.66▼ | 4.34▲ | 4.77▼ |
| MA10 | 4.61▼ | 4.63▼ | 4.55▲ | 4.44▲ | 4.68▼ |
| MA20 | 4.61▼ | 4.49▲ | 4.47▲ | 4.71▼ | 4.69▼ |
| MA50 | 4.50▲ | 4.40▲ | 4.38▲ | 4.71▼ | 5.02▼ |
| MA100 | 4.43▲ | 4.40▲ | 4.57▲ | 4.70▼ | 6.01▼ |
| MA200 | 4.37▲ | 4.66▼ | 4.67▼ | 5.06▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.008▼ | 0.008▲ | 0.026▲ | -0.027▼ | 0.001▲ |
| RSI | 52.690▲ | 56.563▲ | 56.555▲ | 48.324▼ | 46.542▼ |
| STOCH | 74.817 | 69.120 | 85.653▲ | 38.777 | 54.314 |
| WILL %R | -50.000 | -23.711▲ | -23.711▲ | -41.194 | -40.395 |
| CCI | -22.484 | 38.185 | 65.772 | -37.661 | -90.585 |
|
Friday, November 14, 2025 05:18 AM
Q3 2025 Earnings Call Transcript November 13, 2025 TriSalus Life Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.96 EPS, expectations were $-0.17. Operator: Good afternoon, and ...
|
|
Thursday, November 13, 2025 09:42 PM
TriSalus Life Sciences Inc (TLSI) reports a 57% revenue increase, expands its product portfolio, and navigates challenges in manufacturing and reimbursement.
|
|
Thursday, November 13, 2025 04:32 PM
Discover TriSalus Life Sciences' Q3 2025 earnings: 57% revenue growth, new product launches, and a reaffirmed 50% growth outlook.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 4.09 | 4.88 | 3.79 | 4.56 | 146,824 |
| 13/11/25 | 4.50 | 4.53 | 4.00 | 4.39 | 200,485 |
| 12/11/25 | 4.35 | 4.54 | 4.30 | 4.42 | 73,049 |
| 11/11/25 | 4.06 | 4.39 | 4.01 | 4.34 | 63,965 |
| 10/11/25 | 4.44 | 4.499 | 3.99 | 4.00 | 203,022 |
| 07/11/25 | 4.38 | 4.41 | 4.2774 | 4.39 | 64,910 |
| 06/11/25 | 4.41 | 4.50 | 4.2501 | 4.39 | 112,109 |
| 05/11/25 | 4.65 | 4.65 | 4.41 | 4.45 | 111,590 |
| 04/11/25 | 4.76 | 4.80 | 4.63 | 4.70 | 44,392 |
| 03/11/25 | 4.75 | 4.78 | 4.5001 | 4.71 | 54,105 |
|
|
||||
|
|
||||
|
|